Antibiotics (Jun 2022)

Emerging Antibiotic Resistance Patterns Affect Visual Outcome Treating Acute Endophthalmitis

  • Xia-Ni Wu,
  • Yi-Hsing Chen,
  • Lazha Sharief,
  • Ahmed Al-Janabi,
  • Nura Al Qassimi,
  • Sue Lightman,
  • Oren Tomkins-Netzer

DOI
https://doi.org/10.3390/antibiotics11070843
Journal volume & issue
Vol. 11, no. 7
p. 843

Abstract

Read online

Background: Examining the effect of antibiotic resistance, use of intravitreal antibiotics and systemic corticosteroids on visual outcome of eyes with acute endophthalmitis. Methods: We included 226 eyes with acute endophthalmitis, treated using a standardized protocol. Visual outcome up to 12 months was assessed related to biopsy results, antibiotics resistance and treatment regimens. Results: Vitreous biopsies were more likely to be culture-positive (41.1%) than anterior chamber biopsies (21.6%, p p p = 0.03) and receiving intravitreal vancomycin (OR 3.15, 1.18–8.42 95% CI, p = 0.02) were associated with a greater chance of final BCVA ≥ 20/40. Conclusion: Using vitreous taps with intravitreal antibiotics, despite an increase in resistance to both vancomycin and moxifloxacin, results in a final BCVA > 20/200 in half of eyes and ≥20/40 in a third. Early treatment with intravitreal antibiotics should not be delayed.

Keywords